Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A collaboratively designed nurse-driven supine trial protocol for prone, intubated patients ...
15don MSN
MiNK outlines 90-patient randomized phase II ARDS trial with initial data expected in 2H 2026
Q1 2026 Management View Dr. Jennifer Buell (Co-Founder, President, CEO & Director) framed recent disclosures around clinical and mechanistic readouts across oncology and pulmonary indications, saying, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results